4BIO Capital leads oversubscribed $28.4 million Series A financing of March Biosciences
October 23, 2024 08:05 ET
|
4Bio Capital
March Bio is rapidly advancing its innovative autologous chimeric antigen receptor T-cell (CAR-T) therapy, MB-105, in development for the treatment of relapsed and refractory CD5 positive T-cell...
4BIO Capital Portfolio Company Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases
May 16, 2023 08:00 ET
|
4Bio Capital
Press Release 4BIO Capital Portfolio Company Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases Series A follows initial seed...
ESP Logistics Technology Has 1st Closing on $5.0m Series A Round with Japan Post Group As Lead Investor
January 16, 2023 08:00 ET
|
ESP Logistics Technology
LOS ANGELES, Jan. 16, 2023 (GLOBE NEWSWIRE) -- ESP Logistics Technology (ESP), a company dedicated to solving global supply chain problems through our cloud-based geospatial platform, announced that...
RadioMedix announces a $40 million Series A financing for the advancement of novel Targeted Alpha Therapy platform and diagnostic companion radiopharmaceuticals to address unmet needs in oncology; Michael Lee-Chin appointed to the board of the company
October 07, 2022 18:11 ET
|
RadioMedix Inc.
HOUSTON and BURLINGTON, Ontario, Oct. 07, 2022 (GLOBE NEWSWIRE) -- RadioMedix, Inc. (“RadioMedix” or “Company”), a clinical-stage biotechnology company announced an agreement with an entity related...
4BIO Capital Portfolio Company Code Biotherapeutics Closes Upsized and Oversubscribed $75 Million Series A Financing
June 07, 2022 08:30 ET
|
4Bio Capital
Press Release 4BIO Capital Portfolio Company Code Biotherapeutics Closes Upsized and Oversubscribed $75 Million Series A Financing 7 June 2022 London & Greater Philadelphia – 4BIO Capital...
AviadoBioTM Raises $80 million in Series A Financing to Advance Neurodegenerative Gene Therapy Platform
December 02, 2021 02:00 ET
|
Aviadobio Ltd
AviadoBioTM Raises $80 million in Series A Financing to Advance Neurodegenerative Gene Therapy Platform Series A led by New Enterprise Associates (NEA) and co-led by Monograph Capital follows...
ArriVent Biopharma Launches with Up To $150M in Series A Financing and Strategic Licensing Agreement for Clinical-Stage Oncology Asset
June 30, 2021 07:00 ET
|
ArriVent Biopharma
Funds will be used to build ArriVent’s portfolio of innovative in-licensed assets for global development Company enters first licensing agreement with Allist Pharma, granting ArriVent ex-China...
Zylö Therapeutics Closes $4 Million Series A Financing
September 26, 2019 08:00 ET
|
Zylö Therapeutics
GREENVILLE, SC, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., dedicated to developing a transformational topical delivery platform, announced that on September 21, 2019, it effected a...
Sermonix Pharmaceuticals Closes US$26 Million Series A Financing Round Led by WILD Family Office
July 31, 2019 10:00 ET
|
Sermonix Pharmaceuticals LLC
COLUMBUS, Ohio, July 31, 2019 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company focused on the development of female-specific oncology products, today...
Rheostat Therapeutics Announces $23 Million Series A Financing; To Develop Potential Treatments for Neurodegenerative Diseases
November 26, 2018 09:00 ET
|
Rheostat Therapeutics
CAMBRIDGE, Mass., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Rheostat Therapeutics, a biotech company focused on the discovery of novel treatments for neurodegeneration, cognition and rare diseases, today...